Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid (DHA) Enhanced Chicken

Active, not recruitingOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

December 4, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

January 30, 2026

Conditions
Nutrition, Healthy
Interventions
DIETARY_SUPPLEMENT

DHA/EPA fortified chicken plus Placebo

For participants who received DHA/EPA fortified chicken

DIETARY_SUPPLEMENT

non-25(OH)D fortified chicken/eggs plus vitamin D3 supplement

Provided to participants in the group where they consumed non-fortified chicken/eggs

DIETARY_SUPPLEMENT

non-DHA bio-enhanced chicken plus supplement DHA Omega-3

Used in the crossover part of the study given to the group who did not received DHA bio-enhanced chicken

DIETARY_SUPPLEMENT

25(OH)D bioenhanced chicken and eggs plus placebo

participants will receive 25(OH)D bioenhanced chicken and eggs plus a placebo as a dietary intervention

DIETARY_SUPPLEMENT

Dietary Supplement: DHA/EPA fortified eggs plus Placebo

For the participants who received DHA/EPA fortified eggs

DIETARY_SUPPLEMENT

non-DHA bio-enhanced eggs plus supplement DHA Omega-3

for the participants who received non-DHA bio-enhanced eggs plus supplement DHA Omega-3

OTHER

non-25(OH)D fortified chicken/eggs plus placebo

Provided to participants in the group where they consumed non-fortified chicken/eggs + placebo pills

Trial Locations (1)

14850

Human Metabolic Research Unit, Ithaca

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cornell University

OTHER

NCT05248737 - Bioavailability of Vitamin D(25(OH)D) and Omega-3 Fatty Acid (DHA) Enhanced Chicken | Biotech Hunter | Biotech Hunter